pimobendan and isoproterenol
pimobendan has been researched along with isoproterenol in 22 studies
Research
Studies (22)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (40.91) | 18.7374 |
1990's | 10 (45.45) | 18.2507 |
2000's | 1 (4.55) | 29.6817 |
2010's | 2 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Eschenhagen, T; Mende, U; Müller, FU; Neumann, J; Schmitz, W; Scholz, H | 1 |
Fujimoto, S; Matsuda, T | 1 |
Endoh, M; Ishihata, A; Norota, I; Satoh, H; Shibasaki, T | 1 |
Beier, N; Haeusler, G; Harting, J; Jonas, R; Klockow, M; Lues, I | 1 |
Alpert, NR; Blanchard, EM; Hasenfuss, G; Holubarsch, CH; Just, H; Mulieri, LA | 1 |
Berger, C; Meyer, W; Scholz, H; Starbatty, J | 1 |
Alpert, NR; Blanchard, E; Hasenfuss, G; Holubarsch, C; Just, H; Mulieri, LA | 3 |
Allen, DG; Lee, JA; Ruegg, JC | 1 |
Alpert, NR; Blanchard, EM; Mulieri, LA | 1 |
Fujino, K; Solaro, RJ; Sperelakis, N | 1 |
Alpert, NR; Blanchard, EM | 1 |
Heiss, A; Honerjäger, P; Reiter, M; Schäfer-Korting, M; Schönsteiner, G | 1 |
Erdmann, E | 1 |
Holubarsch, C | 1 |
Piano, MR; Rosenblum, C; Schwertz, D; Solaro, RJ | 1 |
Azuma, M; Gando, S; Hattori, Y; Ishitani, T; Kanno, M; Kemmotsu, O; Tomita, F; Yokoshiki, H | 1 |
Bodi, A; Edes, I; Facsko, A; Kovacs, L; Kranias, EG; Kristof, E; Papp, JG; Papp, Z; Szigeti, G | 1 |
Harada, S; Hisatome, I; Miyagawa, S; Morikawa, K; Nakamura, Y; Ninomiya, H; Nishimura, M; Ogino, K; Otsuki, Y; Sawa, Y; Yamamoto, Y | 1 |
Nakata, TM; Shimada, K; Suzuki, K; Tanaka, R; Uemura, A | 1 |
Other Studies
22 other study(ies) available for pimobendan and isoproterenol
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Phosphodiesterase inhibition and positive inotropy in failing human myocardium.
Topics: Benzimidazoles; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Heart; Humans; Imidazoles; Isoenzymes; Isometric Contraction; Isoproterenol; Myocardial Contraction; Myocardium; Organ Culture Techniques; Oxindoles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Pyridazines; Pyridones | 1992 |
Effects of pimobendan, a cardiotonic and vasodilating agent with phosphodiesterase inhibiting properties, on isolated arteries and veins of rats.
Topics: 1-Methyl-3-isobutylxanthine; Aminophylline; Animals; Arteries; Cardiotonic Agents; Colforsin; Drug Interactions; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Pyridazines; Rats; Rats, Inbred Strains; Vasodilator Agents; Veins | 1990 |
Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium.
Topics: Animals; Carbachol; Cardiotonic Agents; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Female; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Propanolamines; Pyridazines; Vasodilator Agents | 1991 |
The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer".
Topics: Adenosine Triphosphatases; Animals; Calcium; Carbachol; Cardiotonic Agents; Cattle; Cyclic AMP; Guinea Pigs; In Vitro Techniques; Isoenzymes; Isometric Contraction; Isoproterenol; Male; Myocardial Contraction; Myocardium; Myofibrils; Papillary Muscles; Phosphoric Diester Hydrolases; Pyridazines; Quinolines; Rats; Rats, Inbred Strains; Thiadiazines | 1991 |
Modulation of myothermal economy of isometric force generation by positive inotropic interventions in the guinea pig myocardium.
Topics: Animals; Calcium; Cardiotonic Agents; Energy Metabolism; Guinea Pigs; Isoproterenol; Myocardial Contraction; Papillary Muscles; Pyridazines; Stimulation, Chemical | 1990 |
Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adenylyl Cyclases; Animals; Carbachol; Cardiotonic Agents; Female; Guinea Pigs; Heart Atria; Histamine; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Ouabain; Papillary Muscles; Phenylisopropyladenosine; Phosphodiesterase Inhibitors; Pyridazines | 1985 |
Influence of the positive inotropic substance pimobendan (UD-CG 115 BS) on contractile economy of guinea pig papillary muscles.
Topics: Animals; Cardiotonic Agents; Guinea Pigs; Heart; Hot Temperature; Isoproterenol; Myocardial Contraction; Ouabain; Papillary Muscles; Pyridazines; Stimulation, Chemical | 1989 |
Effects of pimobendan, a novel inotropic agent, on intracellular calcium and tension in isolated ferret ventricular muscle.
Topics: Aequorin; Animals; Calcium; Cardiotonic Agents; Cyclic AMP; Ferrets; Heart Ventricles; In Vitro Techniques; Isoproterenol; Papillary Muscles; Pyridazines | 1989 |
Energetic consequences of positive inotropic interventions in guinea pig papillary muscles.
Topics: Animals; Body Temperature Regulation; Calcium; Cardiotonic Agents; Energy Metabolism; Guinea Pigs; In Vitro Techniques; Isoproterenol; Papillary Muscles; Pyridazines | 1989 |
The effects of acute and chronic inotropic interventions on tension independent heat of rabbit papillary muscle.
Topics: Animals; Cardiomegaly; Cardiotonic Agents; Heart; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Pyridazines; Rabbits; Thyrotoxicosis | 1987 |
Differential effects of d- and l-pimobendan on cardiac myofilament calcium sensitivity.
Topics: Actin Cytoskeleton; Action Potentials; Animals; Calcium; Cytoskeleton; Dogs; Electrophysiology; Guinea Pigs; Heart; Isomerism; Isoproterenol; Kinetics; Propranolol; Pyridazines | 1988 |
The effects of isoproterenol, UDCG 115, and caffeine on the heart related to excitation-contraction coupling in heart muscle.
Topics: Animals; Caffeine; Calcium; Hot Temperature; Isoproterenol; Kinetics; Male; Myocardial Contraction; Pyridazines; Rabbits; Stimulation, Chemical; Thermodynamics | 1987 |
Energetic aspects of inotropic interventions in rat myocardium.
Topics: Animals; Calorimetry; Cardiotonic Agents; Heart; Heart Ventricles; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Pyridazines; Rats; Rats, Inbred WKY; Thermodynamics; Ventricular Function | 1987 |
UD-CG 115--a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle.
Topics: Action Potentials; Animals; Carbachol; Cardiotonic Agents; Cimetidine; Cyclic AMP; Female; Guinea Pigs; Histamine; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Papillary Muscles; Phosphodiesterase Inhibitors; Propranolol; Pyridazines; Reserpine; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical | 1984 |
The effect of positive inotropes on the failing human myocardium.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Calcium; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Milrinone; Myocardial Contraction; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones | 1997 |
New inotropic concepts: rationale for and differences between calcium sensitizers and phosphodiesterase inhibitors.
Topics: Animals; Calcium; Cardiotonic Agents; Deoxyepinephrine; Energy Metabolism; Guinea Pigs; Heart Failure; Humans; Imidazoles; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Myocardium; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Quinolines; Thiadiazines | 1997 |
Calcium sensitivity and the effect of the calcium sensitizing drug pimobendan in the alcoholic isolated rat atrium.
Topics: Alcohol Drinking; Animals; Atrial Fibrillation; Calcium; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Pyridazines; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |
Cardiac profile of EGIS-9377, a novel cardiotonic agent as a Ca2+ sensitizer with bradycardiac activity.
Topics: Animals; Calcium; Cardiotonic Agents; Depression, Chemical; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Female; Guinea Pigs; Heart; Heart Rate; Heart Ventricles; In Vitro Techniques; Isoproterenol; Male; Morpholines; Myocardial Contraction; Papillary Muscles; Pyridazines; Pyrimidines; Time Factors; Ventricular Function | 1999 |
Cardiac responses to calcium sensitizers and isoproterenol in intact guinea pig hearts. Effects on cyclic AMP levels, protein phosphorylation, myoplasmic calcium concentration, and left ventricular function.
Topics: Animals; Calcium; Cardiotonic Agents; Cyclic AMP; Guinea Pigs; Heart; Hydrazones; Isoproterenol; Muscle Proteins; Myocardium; Phosphorylation; Pyridazines; Quinolines; Simendan; Thiadiazines; Ventricular Function, Left | 1998 |
Adipose stem cell sheets improved cardiac function in the rat myocardial infarction, but did not alter cardiac contractile responses to β-adrenergic stimulation.
Topics: Adipocytes; Animals; Atrial Natriuretic Factor; Atrial Remodeling; Bucladesine; Cardiomegaly; Cell Differentiation; Diastole; Fibroblast Growth Factors; Hepatocyte Growth Factor; Isoproterenol; Male; Myoblasts, Skeletal; Myocardial Contraction; Myocardial Infarction; Myocardium; Organ Culture Techniques; Paracrine Communication; Pyridazines; Rats; Rats, Inbred Lew; Stem Cell Transplantation; Stem Cells; Systole; Vascular Endothelial Growth Factor A | 2015 |
Contrasting Effects of Inhibition of Phosphodiesterase 3 and 5 on Cardiac Function and Interstitial Fibrosis in Rats With Isoproterenol-Induced Cardiac Dysfunction.
Topics: Animals; Arrhythmias, Cardiac; Collagen Type I; Collagen Type III; Disease Models, Animal; Fibrosis; Isoproterenol; Male; Myocardium; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 5 Inhibitors; Pyridazines; Rats, Wistar; Risk Assessment; Sildenafil Citrate; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2019 |